Time to Buy Beat-Down Intec Pharma Ltd (NTEC) Stock? Here is the INSIGHT – Invest Chronicle
Home  »  News   »  Time to Buy Beat-Down Intec Pharma Ltd (NTEC) Stoc...

Time to Buy Beat-Down Intec Pharma Ltd (NTEC) Stock? Here is the INSIGHT

For the readers interested in the stock health of Intec Pharma Ltd (NTEC). It is currently valued at $4.16. When the transactions were called off in the previous session, Stock hit the highs of $4.35, after setting-off with the price of $3.54. Company’s stock value dipped to $3.42 during the trading on the day. When the trading was stopped its value was $3.54.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Recently in News on May 6, 2021, SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies – NTEC, SNX, STAY, MX, MLND. Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:. You can read further details here


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Intec Pharma Ltd had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $9.20 on 02/11/21, with the lowest value was $3.25 for the same time period, recorded on 03/05/21.

Intec Pharma Ltd (NTEC) full year performance was -11.11%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Intec Pharma Ltd shares are logging -73.70% during the 52-week period from high price, and 89.09% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.20 and $15.82.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 3253173 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Intec Pharma Ltd (NTEC) recorded performance in the market was 20.58%, having the revenues showcasing -19.07% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 18.73M, as it employees total of 36 workers.

Market experts do have their say about Intec Pharma Ltd (NTEC)

During the last month, 1 analysts gave the Intec Pharma Ltd a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 1 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 4.42, with a change in the price was noted +0.02. In a similar fashion, Intec Pharma Ltd posted a movement of +0.48% for the period of last 100 days, recording 748,164 in trading volumes.

Technical breakdown of Intec Pharma Ltd (NTEC)

Raw Stochastic average of Intec Pharma Ltd in the period of last 50 days is set at 21.46%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 58.73%. In the last 20 days, the company’s Stochastic %K was 22.99% and its Stochastic %D was recorded 13.46%.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Bearing in mind the latest performance of Intec Pharma Ltd, several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 20.58%. Additionally, trading for the stock in the period of the last six months notably improved by 48.57%, alongside a downfall of -11.11% for the period of the last 12 months. The shares increased approximately by 7.77% in the 7-day charts and went up by -2.35% in the period of the last 30 days. Common stock shares were lifted by -19.07% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam